Analyst Ratings for Amphastar Pharmaceuticals (AMPH)
AMPH Rating Summary
AMPH Price Target Summary
- Highest: $22.00 (Jefferies)
- Lowest: $19.00 (Wells Fargo)
- Average: $20.40
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$20.40 (+3.3%)
* Over Last 12-Mos
Rating Score: 1.8 / 10
Percentile Rank: 13%
Avg. $ Target:
$20.40 (+3.3%)
* Over Last 12-Mos
Rating Score: 1.8 / 10
Percentile Rank: 13%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 6/29/2026 | BofA Securities | Jason Gerberry | Downgrade | Underperform (Neutral) |
20.00 (25.00) |
21.78 (19.75) |
-9.32% | Details |
| 5/14/2026 | Wells Fargo | Benjamin Burnett | Downgrade | Equal Weight (Overweight) |
19.00 (N/A) |
18.32 (19.75) |
7.81% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
